172 material Form 8-K filings that 152 companies we cover made with the SEC in September 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Entegris, Inc. appointed Mary Puma, former president and chief executive officer of Axcelis Technologies, as a director effective September 5, 2024, bringing the board to eight members. The filing describes standard non-employee director pay for Ms. Puma and a board committee assignment that has not yet been determined, so it is routine governance news with limited direct financial effect on shareholders.
Mary Puma appointed to Entegris board effective September 5, 2024; board has determined she is independent under Nasdaq rules
Ms. Puma received a prorated award of 1,207 restricted stock units on September 5, 2024
She will receive a prorated portion of the $105,000 annual non-employee director retainer
Committee assignments not yet determined; Entegris will file an amendment within four business days after they are set
At its September 5, 2024 annual meeting, Hamilton Lane stockholders elected three Class II directors to terms ending at the 2027 annual meeting and approved the Amended and Restated 2017 Equity Incentive Plan, which took effect the same day. Stockholders also approved named executive officer compensation on an advisory basis and ratified Ernst & Young LLP as the independent auditor for the fiscal year ending March 31, 2025. The filing describes routine governance outcomes and does not report financial results.
Equity plan approved with 125,532,615 votes for and 18,481,263 against; it became effective September 5, 2024
Three Class II directors elected: R. Vann Graves, Erik R. Hirsch and Leslie F. Varon, each for a term ending at the 2027 annual meeting
Advisory say-on-pay vote approved with 136,643,258 votes for and 7,373,593 against
Ernst & Young LLP ratified as auditor with 148,255,209 votes for and 252,863 against
Quanex reported fiscal third-quarter 2024 results for the three months ended July 31, 2024, with net sales down 6.4% from a year earlier and diluted EPS down to $0.77 from $0.96. The company said prior 2024 guidance no longer applies after the Tyman acquisition closed August 1, 2024, and issued new full-year estimates that include Tyman's contribution.
Net sales were $280.3 million vs. $299.6 million a year earlier; net income was $25.4 million vs. $31.7 million.
Adjusted diluted EPS was $0.73 vs. $0.97; Adjusted EBITDA was $42.0 million vs. $48.5 million.
New fiscal 2024 estimates: net sales of $1.275 billion to $1.285 billion and Adjusted EBITDA of $171 million to $176 million.
Management cited softer demand and lower operating leverage; a conference call is scheduled for September 6, 2024 at 11:00 a.m. ET.
UiPath reported fiscal second-quarter 2025 revenue of $316 million, up 10% year-over-year, and annual recurring revenue (ARR) of $1.551 billion, up 19%. The company still posted a GAAP operating loss of $103 million and said it raised its full-year profitability guidance, now calling for non-GAAP operating income of about $170 million. The board also authorized an additional $500 million in share repurchases and named CFO Ashim Gupta chief operating officer while he keeps the CFO role.
Q2 fiscal 2025 revenue of $316 million, up 10% year-over-year; ARR of $1.551 billion, up 19%.
GAAP operating loss of $103 million, versus $78 million a year earlier; net loss of $86 million.
Full-year fiscal 2025 guidance: revenue of $1.420 billion to $1.425 billion and non-GAAP operating income of about $170 million.
Board added $500 million to the buyback program, bringing total repurchase capacity to up to $554 million; Gupta named COO effective September 5, 2024.
Guidewire reported unaudited results for the fourth quarter and fiscal year ended July 31, 2024. Fiscal 2024 total revenue rose 8% to $980.5 million, and the GAAP net loss narrowed to $6.1 million from $111.9 million, while fourth-quarter GAAP net income was $16.8 million, up from $12.2 million, though non-GAAP net income for the quarter fell to $54.0 million from $62.8 million.
Fiscal 2024 total revenue was $980.5 million, up 8%; GAAP net loss was $6.1 million, compared with $111.9 million in fiscal 2023.
Fourth-quarter revenue was $291.5 million, up 8%; GAAP net income was $16.8 million, or $0.20 per diluted share, compared with $12.2 million, or $0.15.
Fourth-quarter non-GAAP net income was $54.0 million, compared with $62.8 million a year earlier.
Guidance for fiscal 2025 calls for total revenue of $1,135 million to $1,149 million and ARR of $995 million to $1,005 million.
Argan reported fiscal second-quarter results for the three months ended July 31, 2024, with revenue up 60.6% to $227.0 million and net income of $18.2 million, or $1.31 per diluted share, versus $0.94 a year earlier. Gross margin fell to 13.7% from 16.8%, and backlog reached $1.0 billion at quarter end, which the company says reflects an increase of approximately $210 million from the prior quarter.
Consolidated revenues were $227.0 million, up $85.7 million from $141.3 million a year earlier.
Net income was $18.2 million, or $1.31 per diluted share, compared with $12.8 million, or $0.94 per diluted share.
Gross margin was 13.7%, down from 16.8%, reflecting the changing mix of projects and contract types.
Project backlog was $1.0 billion at July 31, 2024, and cash, cash equivalents and investments totaled $484.7 million.
Docusign reported fiscal second-quarter results for the period ended July 31, 2024, with total revenue up 7% year-over-year to $736.0 million and non-GAAP diluted EPS of $0.97, up from $0.72. GAAP diluted EPS of $4.26 was driven mainly by an income tax benefit of $816.3 million, and the company issued revenue guidance for the October quarter and fiscal 2025.
Total revenue was $736.0 million, up 7% year-over-year; subscription revenue was $717.4 million, and billings were $724.5 million, up 2%.
GAAP diluted EPS was $4.26 versus $0.04 a year earlier; non-GAAP diluted EPS was $0.97 versus $0.72.
Guidance: revenue of $743 million to $747 million for the quarter ending October 31, 2024, and $2.94 billion to $2.95 billion for the fiscal year ending January 31, 2025.
G-III reported second-quarter fiscal 2025 results for the quarter ended July 31, 2024. Net sales fell 2% from a year earlier, while GAAP net income per diluted share rose to $0.53 from $0.35, and the company raised its fiscal 2025 earnings per share outlook to $3.94 to $4.04 while reaffirming its net sales forecast of $3.20 billion. The company also announced a license agreement for the Converse brand, with products expected to launch in Fall 2025.
Net sales fell 2% to $644.8 million from $659.8 million in the prior-year second quarter.
GAAP diluted EPS was $0.53 versus $0.35; non-GAAP diluted EPS was $0.52 versus $0.40.
Fiscal 2025 GAAP diluted EPS outlook raised to $3.94 to $4.04 from $3.58 to $3.68; net sales outlook unchanged at $3.20 billion.
Repaid $400 million senior secured notes due August 2025 and repurchased 1.2 million shares for $31.6 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.